ClinicalTrials.Veeva

Menu

Case Notes Review on Patients With Hereditary Haemorrhagic Telangiectasia

Imperial College London logo

Imperial College London

Status

Enrolling

Conditions

Telangiectasia, Hereditary Hemorrhagic

Study type

Observational

Funder types

Other

Identifiers

NCT00230685
IC/CLS2

Details and patient eligibility

About

This observational study is for individuals with Hereditary haemorrhagic telangiectasia and pulmonary arteriovenous malformations that are reviewed at the Hammersmith Hospital, London.

Full description

The Hammersmith Hospital provides a clinical service for patients with Hereditary haemorrhagic telangiectasia and pulmonary arteriovenous malformations that is unique in the United Kingdom. Measurements obtained as part of standard clinical practice that has evolved since 1985 allow us to assess whether particular groups of individuals that we see are more prone to recognised complications such as strokes, brain abscesses, pregnancy related complications or pulmonary hypertension. We hypothesise that certain clinical characteristics will predict the susceptibility of individuals to particular complications.

Enrollment

2,000 estimated patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients attending Hammersmith Hospital

Exclusion criteria

  • None

Trial contacts and locations

1

Loading...

Central trial contact

Claire L Shovlin

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems